TrialHepatology communications2025
A randomized trial of ascorbic acid for the prevention of post-reperfusion syndrome during liver transplantation.
Luis Gajate Martín et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it